title: Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease.
abstract: Long-term non-progressors (LTNP) were identified after 10-15 years of the epidemic, and have been the subject of intense investigation ever since. In a small minority of cases, infection with nef/3'LTR deleted attenuated viral strains allowed control over viral replication. A common feature of LTNP is the readily detected proliferation of CD4 T-cells in vitro, in response to p24. In some cases, the responding CD4 T-cells have cytotoxic effector function and may target conserved p24 epitopes, similar to the CD8 T-cells described below. LTNP may also carry much lower HIV DNA burden in key CD4 subsets, presumably resulting from lower viral replication during primary infection. Some studies, but not others, suggest that LTNP have CD4 T-cells that are relatively resistant to HIV infection in vitro. One possible mechanism may involve up-regulation of the cell cycle regulator p21/waf in CD4 T-cells from LTNP. Delayed progression in Caucasian LTNP is also partly associated with heterozygosity of the Δ32 CCR5 allele, probably through decreased expression of CCR5 co-receptor on CD4 T-cells. However, in approximately half of Caucasian LTNP, two host genotypes, namely HLA-B57 and HLA-B27, are associated with viral control. Immunodominant CD8 T-cells from these individuals target epitopes in p24 that are highly conserved, and escape mutations have significant fitness costs to the virus. Furthermore, recent studies have suggested that these CD8 T-cells from LTNP, but not from HLA-B27 or HLA-B57 progressors, can cross-react with intermediate escape mutations, preventing full escape via compensatory mutations. Humoral immunity appears to play little part in LTNP subjects, since broadly neutralizing antibodies are rare, even amongst slow progressors. Recent genome-wide comparisons between LTNP and progressors have confirmed the HLA-B57, HLA-B27, and delta32 CCR5 allelic associations, plus indicated a role for HLA-C/KIR interactions, but have not revealed any new genotypes so far. Nevertheless, it is hoped that studying the mechanisms of intracellular restriction factors, such as the recently identified SAMHD1, will lead to a better understanding of non-progression.
authors: Centre for Applied Medical Research, St Vincent's Hospital Darlinghurst, NSW, Australia.
authors: John
authors: J
authors: Zaunders
authors: David
authors: D
authors: van Bockel
keywords: HIV-1; cell-mediated immunity; cytotoxic T lymphocytes; elite controllers; long-term non-progressors
references: Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8869-73
references: 9671771
references: Curr Opin HIV AIDS. 2011 May;6(3):151-6
references: 21378562
references: AIDS. 1991 Jan;5(1):1-14
references: 1812848
references: J Immunol. 2006 May 15;176(10):6130-46
references: 16670322
references: Blood. 2012 May 17;119(20):4645-55
references: 22490332
references: J Intern Med. 2009 Jan;265(1):29-42
references: 19093958
references: AIDS Res Hum Retroviruses. 1996 Dec 10;12(18):1691-8
references: 8959245
references: Nat Genet. 2002 Aug;31(4):429-34
references: 12134147
references: Curr Drug Targets. 2006 Dec;7(12):1571-82
references: 17168832
references: Sci Transl Med. 2012 Feb 29;4(123):123ra25
references: 22378925
references: Front Microbiol. 2012 Mar 15;3:97
references: 22435067
references: Nature. 2000 Sep 28;407(6803):523-6
references: 11029005
references: AIDS. 2005 Nov 18;19(17):2001-7
references: 16260907
references: J Virol. 2000 May;74(9):4361-76
references: 10756051
references: Nat Med. 2010 Apr;16(4):452-9
references: 20208540
references: Lancet. 1999 Nov 20;354(9192):1782-5
references: 10577640
references: Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):E689-98
references: 21873218
references: Retrovirology. 2012 Nov 06;9:91
references: 23131037
references: J Infect Dis. 2008 Jan 1;197(1):126-33
references: 18171295
references: Blood. 2004 Mar 15;103(6):2238-47
references: 14645006
references: Cell. 1990 Apr 20;61(2):213-22
references: 2331748
references: Curr Opin Immunol. 1996 Aug;8(4):472-7
references: 8794015
references: J Infect Dis. 1998 Dec;178(6):1812-5
references: 9815241
references: AIDS Res Hum Retroviruses. 1999 Nov 20;15(17):1519-27
references: 10580402
references: J Virol. 2010 Jun;84(11):5540-9
references: 20335261
references: J Virol. 2006 Oct;80(20):10151-61
references: 17005692
references: J Infect Dis. 2008 Feb 15;197(4):563-71
references: 18275276
references: J Infect Dis. 2005 Jul 1;192(1):46-55
references: 15942893
references: AIDS. 2007 May 11;21(8):1043-5
references: 17457100
references: AIDS. 1997 Dec;11(15):1833-8
references: 9412701
references: J Virol. 2012 Apr;86(7):4014-8
references: 22278241
references: J Virol. 2012 Jan;86(1):277-83
references: 22031937
references: J Immunol. 2010 May 1;184(9):4926-35
references: 20363974
references: Ann Intern Med. 1997 Jun 15;126(12):946-54
references: 9182471
references: AIDS. 2010 Jul 31;24(12):1917-22
references: 20588166
references: Nature. 2002 May 2;417(6884):95-8
references: 11986671
references: Ann Intern Med. 2001 Nov 6;135(9):782-95
references: 11694103
references: Clin Infect Dis. 2012 May;54(10):1495-503
references: 22441653
references: Nat Med. 1996 Nov;2(11):1240-3
references: 8898752
references: J Virol. 2008 Sep;82(17):8422-30
references: 18562530
references: PLoS One. 2008;3(12):e3907
references: 19107206
references: J Infect Dis. 1991 May;163(5):959-65
references: 1673465
references: J Immunol. 2002 Jun 1;168(11):5954-8
references: 12023402
references: J Infect Dis. 2001 Mar 1;183(5):736-43
references: 11181150
references: Trends Immunol. 2003 Dec;24(12):628-32
references: 14644135
references: J Infect Dis. 1999 Jul;180(1):68-75
references: 10353863
references: Science. 1995 Nov 10;270(5238):988-91
references: 7481804
references: PLoS Pathog. 2011 Feb;7(2):e1001300
references: 21383972
references: Immunol Today. 1998 Sep;19(9):395-404
references: 9745202
references: J Virol. 2010 Aug;84(15):7581-91
references: 20504921
references: Annu Rev Med. 2003;54:535-51
references: 12525683
references: Annu Rev Immunol. 2011;29:621-63
references: 21314428
references: Virology. 2002 Dec 20;304(2):246-64
references: 12504566
references: J Biol Chem. 1997 Dec 5;272(49):30603-6
references: 9388191
references: J Virol. 2004 Aug;78(16):8844-51
references: 15280492
references: J Virol. 2007 Dec;81(24):13904-15
references: 17928341
references: Retrovirology. 2008 Sep 22;5:84
references: 18808677
references: J Infect Dis. 1994 May;169(5):968-74
references: 7909549
references: AIDS Res Hum Retroviruses. 2012 Dec;28(12):1565-73
references: 22530776
references: J Acquir Immune Defic Syndr. 2006 Jun;42(2):192-202
references: 16688094
references: Proc Natl Acad Sci U S A. 2005 May 17;102(20):7239-44
references: 15872023
references: Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2709-14
references: 10694578
references: Immunity. 1999 Jun;10(6):661-71
references: 10403641
references: Nature. 1998 Jan 22;391(6665):397-401
references: 9450757
references: AIDS. 2002 May 3;16(7):961-72
references: 11953462
references: Science. 1996 Sep 27;273(5283):1856-62
references: 8791590
references: Annu Rev Immunol. 1999;17:625-56
references: 10358770
references: Retrovirology. 2013 Jan 07;10:1
references: 23289738
references: J Virol. 1997 Apr;71(4):3120-8
references: 9060675
references: Blood. 1998 Nov 1;92(9):3105-14
references: 9787145
references: Nat Med. 2007 Jan;13(1):46-53
references: 17173051
references: J Virol. 2007 Nov;81(22):12382-93
references: 17804494
references: J Infect Dis. 1999 Aug;180(2):320-9
references: 10395845
references: J Exp Med. 1998 Dec 21;188(12):2199-204
references: 9858506
references: J Immunol. 2012 Mar 1;188(5):2198-206
references: 22287716
references: Clin Dev Immunol. 2012;2012:153863
references: 23227083
references: J Virol. 2011 Mar;85(5):2316-24
references: 21159862
references: Nat Rev Immunol. 2010 Jan;10(1):11-23
references: 20010788
references: Nat Med. 2010 Oct;16(10):1147-51
references: 20890291
references: N Engl J Med. 2009 Oct 15;361(16):1548-59
references: 19828532
references: J Immunol. 2011 Jan 1;186(1):479-88
references: 21115730
references: Eur J Immunol. 2013 Feb;43(2):510-20
references: 23129528
references: J Clin Invest. 2012 Sep;122(9):3281-94
references: 22922258
references: Nature. 2010 May 20;465(7296):350-4
references: 20445539
references: J Virol. 2004 May;78(9):4463-77
references: 15078927
references: N Engl J Med. 1991 Apr 4;324(14):954-60
references: 1900576
references: J Virol. 2009 Sep;83(17):8616-27
references: 19515764
references: Science. 2010 Dec 10;330(6010):1551-7
references: 21051598
references: J Exp Med. 2007 Nov 26;204(12):2813-24
references: 18025130
references: Nat Med. 2009 Aug;15(8):893-900
references: 19543283
references: PLoS Pathog. 2009 Apr;5(4):e1000377
references: 19360131
references: J Clin Invest. 1989 Dec;84(6):1892-9
references: 2574188
references: J Infect Dis. 2007 Jun 15;195(12):1762-4
references: 17492591
references: J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):140-47
references: 18300365
references: Nature. 2006 Sep 21;443(7109):350-4
references: 16921384
references: Nat Immunol. 2012 Jun 10;13(7):691-700
references: 22683743
references: Blood. 2009 Jul 9;114(2):346-56
references: 19365081
references: J Exp Med. 2009 Jun 8;206(6):1253-72
references: 19487423
references: J Virol. 2011 Jan;85(2):979-86
references: 21068257
references: Blood. 2011 Jul 28;118(4):955-64
references: 21642597
references: Clin Infect Dis. 2005 Oct 1;41(7):1053-6
references: 16142675
references: J Immunol. 2010 Jul 1;185(1):498-506
references: 20519650
references: J Infect Dis. 2011 Mar 15;203(6):803-9
references: 21257739
references: PLoS Pathog. 2012;8(3):e1002529
references: 22412369
references: J Virol. 2013 Apr;87(7):3760-73
references: 23325697
references: J Virol. 2006 Oct;80(20):10162-72
references: 17005693
references: J Exp Med. 2007 Nov 26;204(12):3027-36
references: 18025129
references: J Exp Med. 2012 Jul 30;209(8):1391-5
references: 22851641
references: J Infect Dis. 2005 May 1;191(9):1410-8
references: 15809898
references: Top HIV Med. 2007 Aug-Sep;15(4):134-6
references: 17720999
references: J Clin Invest. 1988 Dec;82(6):1908-14
references: 2974045
references: Blood. 2005 Sep 1;106(5):1660-7
references: 15905189
references: Science. 2007 Aug 17;317(5840):944-7
references: 17641165
references: Ann Intern Med. 1995 Apr 15;122(8):573-9
references: 7887550
references: Nat Immunol. 2002 Nov;3(11):1061-8
references: 12368910
references: J Virol. 2004 Jan;78(2):630-41
references: 14694094
references: PLoS Pathog. 2013 Mar;9(3):e1003211
references: 23516360
references: AIDS. 2010 Nov 13;24(17):2619-28
references: 20881472
references: Eur J Immunol. 1997 Dec;27(12):3223-7
references: 9464809
references: Nat Rev Microbiol. 2007 Feb;5(2):95-106
references: 17224919
references: J Exp Med. 2006 Dec 25;203(13):2865-77
references: 17158960
references: AIDS. 2003 Jan 24;17(2):264-7
references: 12545090
references: Semin Immunol. 2008 Jun;20(3):181-6
references: 18595731
references: Clin Infect Dis. 2009 Sep 15;49(6):982-6
references: 19681706
references: Nature. 1994 Jun 2;369(6479):403-7
references: 7515165
references: AIDS. 2004 Mar 26;18(5):749-55
references: 15075509
references: J Clin Invest. 2011 Apr;121(4):1549-60
references: 21403397
references: Nature. 2011 May 25;474(7353):654-7
references: 21613998
references: Science. 1997 Nov 21;278(5342):1447-50
references: 9367954
references: Retrovirology. 2008 Dec 11;5:112
references: 19077215
references: J Immunol. 2012 Apr 1;188(7):3247-56
references: 22387550
references: Eur J Immunol. 2001 Dec;31(12):3782-8
references: 11745399
references: J Exp Med. 2004 Sep 20;200(6):701-12
references: 15381726
references: Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16233-8
references: 17911249
references: Nat Immunol. 2012 Feb 12;13(3):223-228
references: 22327569
references: Cell. 1998 May 29;93(5):673-6
references: 9630211
references: Nature. 2010 Mar 11;464(7286):217-23
references: 20220840
references: Nat Med. 1997 Feb;3(2):212-7
references: 9018241
references: J Clin Invest. 2001 Feb;107(4):505-17
references: 11181650
references: Nat Rev Immunol. 2004 Aug;4(8):630-40
references: 15286729
references: Virology. 2010 Sep 15;405(1):81-92
references: 20561662
references: J Virol. 2011 Jan;85(2):733-41
references: 21047960
references: N Engl J Med. 1995 Jan 26;332(4):209-16
references: 7808486
references: J Immunol. 1999 Oct 15;163(8):4597-603
references: 10510404
references: Nat Med. 2002 May;8(5):493-9
references: 11984594
references: AIDS. 2011 Nov 13;25(17):2069-78
references: 21860347
references: J Exp Med. 2007 Oct 1;204(10):2473-85
references: 17893201
references: Nature. 2000 Sep 21;407(6802):386-90
references: 11014195
references: Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6776-81
references: 17428922
references: Nature. 2001 Jul 19;412(6844):334-8
references: 11460164
references: J Immunol. 2007 Mar 1;178(5):2746-54
references: 17312117
references: J Exp Med. 2001 Feb 5;193(3):375-86
references: 11157057
references: J Virol. 2012 Sep;86(18):9802-16
references: 22761389
references: Blood. 2006 Jun 15;107(12):4781-9
references: 16467198
references: J Infect Dis. 2010 Jan 15;201(2):272-84
references: 20001854
references: J Virol. 2010 Apr;84(7):3644-53
references: 20071583
references: Annu Rev Microbiol. 1996;50:825-54
references: 8905100
references: Nature. 2011 Jun 29;474(7353):658-61
references: 21720370
references: Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9791-6
references: 19478057
references: Nature. 2011 Nov 06;480(7377):379-82
references: 22056990
references: Science. 2010 Aug 13;329(5993):811-7
references: 20616231
references: PLoS Pathog. 2010 Feb 26;6(2):e1000780
references: 20195518
references: Retrovirology. 2007 Sep 23;4:66
references: 17888184
references: J Clin Invest. 2012 Sep;122(9):3271-80
references: 22922259
references: J Immunol. 2008 Oct 1;181(7):5137-46
references: 18802118
references: PLoS Pathog. 2008 Feb 8;4(2):e18
references: 18248091
references: J Immunol. 2011 Jan 1;186(1):359-71
references: 21135165
references: Annu Rev Immunol. 2004;22:745-63
references: 15032595
references: Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13878-83
references: 11717444
references: Nature. 2011 Apr 28;472(7344):495-8
references: 21499264
references: Blood. 2009 Jun 18;113(25):6351-60
references: 19389882
references: J Virol. 2007 Mar;81(5):2508-18
references: 17151109
references: Nature. 2011 Sep 22;477(7365):466-70
references: 21849977
references: AIDS. 1995 Jun;9(6):561-6
references: 7662193
references: J Virol. 1994 Jul;68(7):4650-5
references: 8207839
references: J Exp Med. 2001 Jan 15;193(2):181-94
references: 11148222
references: PLoS One. 2012;7(2):e29844
references: 22363409
references: J Infect Dis. 2009 Dec 1;200(11):1714-23
references: 19852669
references: Lancet. 1985 Mar 9;1(8428):537-40
references: 2857899
references: J Infect Dis. 1998 Mar;177(3):551-6
references: 9498431
references: Nat Immunol. 2007 Nov;8(11):1246-54
references: 17906628
references: Lancet. 1992 Oct 10;340(8824):863-7
references: 1357294
references: Clin Infect Dis. 2010 Jul 15;51(2):233-8
references: 20550452
references: AIDS. 2003 Dec 5;17(18):2581-91
references: 14685052
references: Science. 1986 Dec 19;234(4783):1563-6
references: 2431484
references: J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):127-31
references: 21792067
references: Hum Immunol. 2004 May;65(5):486-92
references: 15172448